Completed NA INTERVENTIONAL 1-arm NCT02923297

GALIG Gene Expression in Parkinson's Disease (GALIGPARK)

Sponsor: Centre Hospitalier Régional d'Orléans

Updated 8 times since 2017 Last updated: Aug 31, 2020 Started: Apr 30, 2015 Primary completion: Jun 30, 2015 Completion: Jun 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Parkinson Disease, this trial is completed. The trial is conducted by Centre Hospitalier Régional d'Orléans and has accumulated 8 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Oct 2020 — Jan 2021 [monthly]

Completed NA

▶ Show 3 earlier versions

Jun 2018 — Oct 2020 [monthly]

Completed NA
Apr 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Apr 2017 [monthly]

Completed NA

First recorded

Apr 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier Régional d'Orléans
National Scientific Research Centre

Data source: Centre Hospitalier Régional d'Orléans

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Orléans, France